Takeda
Whoa! How did you get here? This company profile is not meant to be publicly available. Research on this company is incomplete, and the overall rating has been disabled, but while you are here feel free to have a look at the info we do have.
OVERALL |
|
Owned |
JPN |
Rating |
N/A |
Pharmaceuticals
Founded in Japan in 1781. Asia's largest pharmaceutical company.
Takeda Pharmaceutical Company Ltd | JPN | website |
Company Assessment
PRAISE | CRITICISM | INFORMATION | ||
Takeda Pharmaceutical Company Ltd | ||||
In 2023, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change score of A.
Source: CDP (2023)
In 2023, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to manage and govern freshwater resources. Responding companies are scored on six key metrics: transparency; governance & strategy; measuring & monitoring; risk assessment; targets & goals; and value chain engagement. This company received a CDP Water Security score of B.
Source: CDP (2023)
This company received the seventh highest score in the Access to Medicine Index 2022, a ranking of the world's 20 largest pharmaceutical companies on their efforts to increase access to medicine in developing countries. The ranking is based on their scores in each Technical Area, with Product Delivery weighted most highly, followed by R&D and Governance of Access.
Source: Access to Medicine Foundation (2022)
This company received an S&P Global ESG Score of 75/100 in the Pharmaceuticals category of the S&P Global Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices (last updated 23 Sep 2022). The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
Source: S&P Global (2022) |
More than 10,000 Actos lawsuits accused Takeda Pharmaceuticals of failing to adequately warn patients of the risks of bladder cancer, heart failure and other side effects associated with the Type 2 diabetes drug. Without admitting guilt - and continuing to stand by the drug's effectiveness - Takeda settled roughly 9,000 claims for $2.4 billion in 2015.
Source: Drugwatch (2015)
The Green Supply Chain Corporate Information Transparency Index (CITI) evaluates consumer-facing companies that have a sizeable supply chain in China. The evaluation uses government supervision data and public information to assess the environmental management of their supply chains in China. This company received a score of 13.72/100 (retrieved 24 Nov 2023).
Source: IPE (2023)
The 2022 Nature Benchmark ranks 400 companies across eight industries on their efforts to protect our environment and its biodiversity. The companies were assessed using three measurement areas: governance and strategy; social inclusion and community impact; and ecosystems and biodiversity. This company ranked #127/400, with a total score of 19.6/100.
Source: World Benchmarking Alliance (2022) |
In 2014 this company was one of two companies fined by a US jury in Louisiana for a record $9 billion for hiding an alleged link between the best selling diabetes medicine, Actos, and bladder cancer. This company, which developed Actos, was ordered to pay $6 billion. The $9 billion fine was later reduced to $36.8 millon, with Takeda to pay $27.6 million.
Source: Reuters (2014)
As listed on the We Mean Business website, this company has committed to the following climate action initiatives: adopt a science-based emissions reduction target.
Source: We Mean Business (2021)
This company was named in Seramount's 100 Best Companies 2022 for being a mum-friendly employer. Listed companies provide inclusive benefits for families, including paid gender-neutral parental leave, phase-back programs, bereavement leave after miscarriage, reimbursement for fertility expenses, and increased mental health benefits for employees.
Source: Seramount (2022)
This company has extensive corporate responsibility claims on its website in the areas of human rights, labor, environment, anti-corruption and community support.
Source: company website (2020)
In 2023, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts towards removing commodity-driven deforestation and forest degradation from its direct operations and supply chains. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Forests score of C.
Source: CDP (2023)
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
Source: Open Secrets (2020) |
Company Details
Type | Public company |
Revenue | 19.3 billion USD (2018) |
Employees | 49,578 (2019) |
Subsidiaries | Takeda Pharmaceuticals Australia Pty Ltd
Pharmaceuticals |
Contact Details
Address | Tokyo, Japan |
Website | www.takeda.com |